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Abstract A 1.8 mT, bone healing, electromagnetic field (EMF) 
and power frequency EMFs of 0.1 and 0.4 mT significantly 
inhibit DNA synthesis in otherwise unstimulated Jurkat (E 6.1) 
cells. Inhibition is generally most prominent in cells from mid log 
phase growth. In complete medium the bone healing EMF 
inhibits I3H] thymidine uptake of the latter cells by almost 50% 
vs. 20-25% inhibition by 60 Hz fields. Cells in conditioned 
medium are even more sensitive to EMFs with inhibition up to ca. 
60%. The effects of the 0.1 and 0.4 mT power frequency EMFs 
were very similar suggesting saturation at 0.1 mT or lower. 
© 1997 Federation of European Biochemical Societies. 
Key words: Electromagnetic field; DNA synthesis; Growth; 
T-lymphocyte; Jurkat T-cell line 
1. Introduction 
With increasing generation and use of electricity, interest in 
how electromagnetic fields (EMFs) affect human health has 
become an important societal issue. Epidemiological studies 
indicate a positive association between 50/60 Hz power trans-
mission fields and cancer, especially leukemia and lymphomas 
[1-3], but in clinical applications certain EMFs induce healing 
in otherwise non-healing fractures and wounds [4]. These re-
sults have combined to stimulate interest in uncovering the 
mechanism of action of EMFs with the aim of optimizing 
their role in human health. Although controversial, results 
from well controlled laboratory studies now strongly support 
the existence of a significant relationship between EMFs and a 
wide variety of biological processes at the cellular level. How-
ever, it remains unclear how EMF signals are transduced into 
biological signals, how they are linked to biological responses, 
and how these events might be related to human health. 
In this study we investigated how two distinctly different 
EMFs affect Jurkat cell proliferation; power frequency (60 
Hz) EMFs which are epidemiologically related to negative 
effects on human health, and a bone healing field (Electro 
Biology Inc.). Power frequency EMFs were studied at 0.1 
and 0.4 mT, while the bone healing field was studied at 1.8 
mT, the intensity employed in therapeutic settings. 
In the Jurkat lymphoblastoma cell line Lindstroem and 
coworkers showed that power frequency EMFs modulate sig-
nal transduction coupled to the T-cell receptor. Low intensity 
50 Hz EMFs increased cellular Ca2+ oscillations [5], and in-
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ositol triphosphate (IP3) levels [6] and Ca2+ chelators did not 
block the EMF effect on IP3. Moreover, in another CD45 
deficient Jurkat cell line, EMFs did not induce Ca2+ oscilla-
tions [7]. Since CD45 regulates tyrosine kinase coupled to the 
T-cell receptor, these findings suggest that the targets of mag-
netic fields are very early in the signal transduction pathway. 
Liburdy and Eckert corroborated this idea by finding that 0.1 
mT, 60 Hz EMFs increase high affinity anti-CD3 binding to 
the T-cell receptor [8], a result reproduced in our laboratory 
[9]. 
It is well known that antigens can control lymphocyte sig-
nal transduction and upregulate proliferation, while in other 
situations modification of the signal transduction pathway can 
lead to apoptosis, removing potentially harmful T-lympho-
cytes from the cell population. Thus, EMFs acting early in 
signal transduction might result in either cell proliferation or 
apoptosis depending upon how they influence downstream 
events. The research we report here was designed to determine 
if EMF effects at the level of the Jurkat T-cell receptor can be 
propagated through the entire signal transduction pathway 
leading to downstream effects on cell proliferation and/or 
apoptosis. 
Our results indicate that Jurkat cells react to EMF stimu-
lation of the T-cell receptor with cell cycle arrest and thus 
behave like normal T-lymphocytes stimulated by antigens at 
the T-cell receptor (e.g. anti-CD3). Specifically, our results 
show that 60 Hz fields decrease DNA synthesis of Jurkat cells 
as would be expected if EMFs interact with the T-cell receptor 
in the absence of a costimulatory signal. Remarkably, the 
bone healing field which has a 15 cps duty cycle with 4.5 ms 
bursts of 4444 cps saw tooth pulses during each cycle also 
inhibited DNA synthesis, but to an even greater extent. We 
also demonstrated that cell sensitivity to EMFs is highly re-
lated to the growth state of cells and that cells in early and 
late log phase growth are relatively insensitive to EMFs while 
cells in mid log phase are most susceptible to EMF exposure. 
2. Material and methods 
2.1. Cells 
American Type Culture Collection Jurkat cells (E6.1) were grown in 
complete medium consisting of RPMI 1640 supplemented with 10% 
heat inactivated FBS, penicillin (50 U/ml), streptomycin (50 μg/ml), 
fungizone (2.5 μg/ml) and L-glutamine (0.29 mg/ml). Conditioned me-
dium was prepared by growing cells to a defined stage of log phase 
growth in complete medium, harvesting the medium and storing it for 
1 week at —30°C. Cells were grown in a Forma tissue culture incu-
bator at 37°C in a humidified 5% CO2 atmosphere. In our early 
experiments, cells were maintained in continuous log phase culture 
(2x 105—1X 106 cells/ml) by passing cells three times each week. How-
ever, for most of the experiments presented here we regulated the 
stage of cell growth more rigorously. Jurkat cells from a —70°C cell 
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bank were thawed, seeded at 1 X 105 cells/ml in T 25 tissue flasks, and 
grown for 24 h, 72 h and 120 h; early, middle and late log phase 
respectively. In the following, cells harvested at these points of the 
growth curve are referred to as stages 1, 2 or 3 cells (cf. inset to Figs. 2 
and 3). Cells were counted using a hemocytometer or Model Z Coult-
er Counter. Cell viability was assessed by trypan blue dye exclusion. 
2.2. Exposure to EMFs 
The clinical bone healing apparatus was provided by Electro Biol-
ogy Inc., Parsippany, NJ. It consists of a 22 cm (diameter) Helmholtz 
coil-pair driven by a 15 cps duty cycle. Each duty cycle of the signal 
consists of 20, 1.8 mT saw tooth pulses delivered for 4.5 ms, followed 
by a refractory period of about 62 ms [10]. 
In some experiments (Fig. 1) 0.1 mT and 0.4 mT, 60 Hz sinusoidal 
EMFs were generated by an AC signal generator (Jackson Electrical 
Instrument Co.) amplified by a 50 Watt/channel Macintosh audio 
amplifier (model MC 250). This signal was delivered to a 29 cm 
diameter Helmholtz coil-pair. The voltage, current and waveform of 
the amplifier output were continuously monitored during experiments. 
Fast Fourier transform analysis of the signal using an Ono Sokki 
model CF-350 analyzer showed that it contained first, second and 
third harmonics with intensities of —35 db, —63 db and —67 db 
respectively. In the same analysis the 60 Hz signal had an intensity 
of 10.5 db. For all other experiments (Figs. 2 and 3) the same signal 
generator and monitors were used to drive a double wound 38 cm/ 
side, 3 square coil Merritt system [11] with a uniform magnetic field of 
±3.5% over an area of about 100 cm2 at the exposure site in the 
center of the field. All magnetic fields were mapped and monitored 
using a DC and a 60 Hz magnetometer (Integrity Design and Re-
search Corp.). 
For EMF exposures cells were at a density of 1 X 106 cells/ml and 
the experimental EMF was horizontal and oriented in a North to 
South direction. Exposure to EMFs for 20 min with the Helmholtz 
or Merritt coil was inside a dedicated tissue culture incubator (37°C, 
humidified 5% CO2). Controls were maintained in an identical incu-
bator located next to the incubator with the coils. During experiments 
the temperature within the coil systems was monitored with a remote 
sensing, electronic thermometer (Yellow Springs Instrument Co.) and 
remained constant ( ± 0.5°C) during the 20 min exposure time. 
2.3. DNA synthesis assay 
Fifty microliters of Jurkat cells at 1 X 10e cells/ml, in complete or 
conditioned medium were plated in the center wells of 96 well plates. 
Experimental and control plates were treated as described above. Im-
mediately thereafter 180 μΐ complete or conditioned growth medium 
was added to each well. On each of the following 4 days, 20 μΐ [3Η] 
thymidine (0.1 μθ/piιι) was added to wells in an experimental and 
control plate. After a 3 h incubation period, (37°C, humidified 5% 
CO2), cells were harvested on glass filters using a PHD cell harvester 
(Cambridge Technology Inc., MA). Radioactivity on the filters was 
measured by liquid scintillation counting. 
A minimum of 4 replicate cultures were tested at each data point. 
Data are presented as the mean of replicates. Non-linear regression 
and ANOVA analysis were performed using Graphpad's Prism, ver. 
2.0. 
3. Results 
3.1. EMF effects in randomly harvested log phase cells 
Jurkat cells were randomly harvested at various stages of 
log phase growth. The growth characteristics of EMF treated 
and control cells were compared over the next 4 days by 
assaying [3H] thymidine incorporation into DNA. Often, there 
was very little difference between experimental and control 
cultures but sometimes thymidine uptake was significantly de-
creased in EMF treated cells. In cases where field effects were 
significant they did not become apparent until more than 24 h 
after EMF exposure. The difference between experimental and 
control cultures in these experiments generally increased over 
the next two days. Fig. 1 shows results of 5 identical, paired, 
early experiments, in which [3H] thymidine incorporation was 
measured 72 h after exposure to the 1.8 mT pulsed bone 
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Fig. 1. Effect of the 1.8 mT bone healing field on [3H] thymidine in-
corporation of Jurkat cells. Cells were randomly harvested in log 
growth, stimulated for 20 min with the bone healing field and after 
72 h [3H] thymidine uptake was measured. In those experiments we 
obtained variable results from no effect until almost 60% inhibition 
of DNA synthesis. The bars indicate one standard deviation of 8 
replicate cultures. 
healing field. Although all of the experiments showed the 
same trend (i.e. decreased [3H] thymidine uptake in EMF 
stimulated cultures) the effect was significant only in Experi-
ments 1 and 2 (Fig. 1) and in these cases the extent of the field 
effect was quite different (58% in Experiment 1 and 9% in 
Experiment 2). Since all of the experiments were initiated 
with the same number of viable cells these results suggested 
that sometimes EMFs either altered the doubling time of the 
cultures or removed a population of cells from the cell cycle. 
Statistical analysis on the complete growth curves led to the 
conclusion that there was no significant difference between the 
doubling time of EMF treated and control cells, indicating 
that EMF treatment removed some cells from the dividing 
population. Parallel experiments in which cultures were ex-
posed to 0.1 mT or 0.4 mT, 60 Hz EMFs exhibited the 
same trends. EMF treatment usually diminished [3H] thymi-
dine incorporation into DNA, but significant effects were only 
observed in a small number of cases (data not shown). 
3.2. Growth properties of defined log phase cells 
Based on the latter results we hypothesized that either the 
experiments in which we observed an EMF effect were due to 
chance, or the metabolic state of cells varied significantly from 
experiment to experiment and that cells in certain metabolic 
states were more sensitive to EMFs than in others. One way 
that such a differential cell sensitivity might be explained is if 
EMFs interact specifically with cells at a relatively narrow 
well defined point of the cell growth curve (e.g. early, middle 
or late log phase). To investigate this, we performed a series of 
identical experiments on cells from defined points of the 
growth curve. Early, middle or late log phase cells (see Section 
2) were isolated, replated at 106 cells per culture, exposed to 
EMFs, and their ability to synthesize DNA (compared to 
controls) was tested over the next several days. Furthermore, 
to test if growth factor depletion, or accumulation of metab-
olites in the medium might also be involved in causing our 
variable EMF effects, we performed experiments on cells re-
suspended in complete and conditioned medium. 
One important question of interest was whether cells in 
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Fig. 2. Effect of the 1.8 mT bone healing field on [3H] thymidine incorporation of Jurkat cells. Cells were isolated at stage 1, 2 or 3 of the 
growth curve (see insets), resuspended in complete medium (left panels) or conditioned medium (right panels), stimulated for 20 min with the 
bone healing field and [3H] thymidine uptake (3 h pulses) assayed over the next four days. The bars indicate the standard deviations of four 
replicate cultures, eight in case of controls. 
different stages of log phase cell growth were metabolically 
different, and if this might account for our variable results 
shown above. To study this, cells harvested from one culture 
at stage 1, 2 or 3 of log phase growth were transferred to new 
medium (either complete or conditioned) and tested for their 
subsequent [3H] thymidine uptake and sensitivity to EMFs. 
Fig. 2, panels a-d, demonstrate that the daily, pulsed, [3H] 
thymidine uptake of control cells generally increased exponen-
tially, reflecting continued exponential growth of these cul-
tures. However, the length of the period of log phase growth 
varied depending on the growth stage from which the cells 
were harvested and on the medium in which the cells were 
resuspended prior to EMF treatment. 
Control cells harvested at stage 1 continued exponential 
growth with a doubling time of 21 h (R2, 0.99) over the 96 
h experimental period regardless of the medium used to re-
suspend them (Fig. 2, panels a and b). However, stage 2 cells 
exhibited markedly different results than might have been ex-
pected from experiments with stage 1 cells. For example we 
expected control cells harvested in mid log phase and resus-
pended in fresh complete medium (Fig. 2, panel c) to continue 
growth like the control cells shown in Fig. 2, panel a. How-
ever, stage 2 cells had a much shorter doubling time (16.9 h, 
R2, 0.99) and log phase growth ended around 72 h. Stage 3 
cells (Fig. 2, panel e) exhibited a doubling time similar to that 
of stage 1 cells (21.8 h, R2, 0.98) but after 72 h these cells also 
exhibited growth arrest. These results indicate that cells at 
different stages of log phase growth have significantly different 
metabolic states. 
3.3. Effects of the 1.8 mT bone healing field on defined log 
phase cells 
The duty cycle, waveform and frequency of the 1.8 mT 
bone healing field are markedly different from those of the 
0.1 and 0.4 mT, 60 Hz, power frequency fields that we used. 
Moreover, the mechanism by which EMFs induce their bio-
logical activity is unknown and thus the biologically impor-
tant property(s) of the EMFs are also unknown. Because of 
these considerations we present the results of the bone healing 
field and power frequency fields in two separate sections. 
The effects of bone healing EMFs on [3H] thymidine incor-
poration depended on the metabolic state of the cells studied 
(i.e. phase 1, 2, or 3 cells). In the 1st and 2nd generation after 
replating in complete medium no obvious difference was seen 
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Fig. 3. Effects of the 0.1 mT and 0.4 mT 60 Hz electromagnetic fields on [3H] thymidine incorporation of Jurkat cells. Cells were treated in the 
same way as described in Fig. 2. 
between control and treated cells regardless of their metabolic 
state (Fig. 2). However, at 48 h and later [3H] thymidine 
uptake of EMF treated stage 1 and stage 2 cells was clearly 
decreased compared to paired controls and inhibition was 
most prominent in stage 2 cells (42% at 72 h in stage 2 cells 
vs. 22% in stage 1 cells; one-way ANOVA, P<0.01). Fur-
thermore, when the log phase growth period of these cultures 
was analyzed by two-way ANOVA, [3H] thymidine uptake of 
EMF treated cells was found to be significantly different from 
controls (P< 0.0001). In contrast, stage 3 cells replated in 
complete medium were refractory to EMFs (Fig. 2, panel e). 
A further question was if EMF effects on Jurkat cells are 
influenced by factors that accumulate or are depleted from 
conditioned medium. To study this we tested the effect of 
EMFs on cells replated in conditioned medium. The EMFs 
inhibited [3H] thymidine uptake in cells taken from all stages 
of growth (Fig. 2, panels b, d, f) and the magnitude of inhib-
ition increased with increasing culture age (16, 57 and 99% in 
stage 1, 2 and 3 cells respectively). 
In comparing [3H] thymidine uptake of cells grown in com-
plete vs. conditioned medium it is clear that the medium had a 
marked effect on thymidine uptake and sensitivity of cells to 
EMFs. EMFs depressed thymidine uptake of stage 2 cells in 
complete medium by 42% vs. 57% in conditioned medium. 
Although EMFs have little or no effect on stage 3 cells in 
complete medium, in conditioned medium the EMF effect is 
very striking (99% inhibition). 
3.4. Effects of sinusoidal 60 Hz fields on defined log phase cells 
Like 1.8 mT fields, power frequency EMFs generally inhib-
ited [3H] thymidine uptake by Jurkat cells (Fig. 3). In two-way 
ANOVA analysis the inhibition of [3H] thymidine uptake of 
stage 1 and stage 2 cells by 60 Hz fields was always signifi-
cantly different from controls (P < 0.0001). Power frequency 
Table 1 
Inhibition of DNA synthesis in stage 2 cells in complete medium 
0.1 mT 
60 Hz 
% Inhibition 
0.4 mT 
60 Hz 
% Inhibition 
1.8 mT 
Bone healing EMF 
% Inhibition 
Experiment 1 
Experiment 2 
Experiment 3 
22.7 
21.2 
24 
17 
27.5 
14 
41.4 
33.9 
30 
Experiment 1 is the 72 h maximum inhibition time point taken from 
Figs. 2 and 3, panels c, while Experiments 2 and 3 represent the 
maximum inhibition time point which occurred at 48 h after field 
treatment. Other conditions were as described in Section 2. 
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fields generally had no significant effect on stage 3 cells, except 
in conditioned medium where the 0.4 mT field inhibited the 72 
h [3H] thymidine uptake by 76%. With the 1.8 mT bone heal-
ing field stage 2 cells appeared most sensitive to EMFs and 
the effect was most prominent at 72 h. Similar trends were 
observed with cells exposed to the 0.1 and 0.4 mT power 
frequency fields (Fig. 3, panels c, d). Likewise, with power 
frequency fields the magnitude of the EMF effect in all stages 
was greater in conditioned medium compared to cells in com-
plete medium. For example, in stage 2 cells the inhibition 
induced by 0.1 mT fields in complete medium was 23% com-
pared to 54% in conditioned medium and the 0.4 mT field 
induced inhibition by 17 and 35% respectively. Unexpectedly, 
the 0.4 mT and 0.1 mT field effects on [3H] thymidine uptake 
were not significantly different from each other even though 
both fields were significantly different from controls. This re-
sult suggests that the 60 Hz EMF effect is already saturated at 
a field strength of 0.1 mT. 
In continuing experiments with stage 2 and stage 3 cells in 
complete medium (Table 1) we again found stage 2 cells to be 
responsive to all the EMFs tested and stage 3 cells to be 
refractory to EMF treatment. In all experiments DNA syn-
thesis of stage 2 cells treated either with the 60 Hz or bone 
healing EMFs was significantly decreased compared to con-
trols. Moreover, although the time varies at which maximum 
inhibition is observed (72 h in Experiment 1 and 48 h in 
Experiments 2 and 3) the inhibition of DNA synthesis asso-
ciated with exposure to EMFs is remarkably constant from 
experiment to experiment as shown in Table 1. 
4. Discussion 
We investigated the effect of two different kinds of EMFs 
on DNA synthesis of Jurkat cells. The bone healing field 
(described in Section 2) is widely employed therapeutically 
to treat non-healing bone fractures and weak 60 Hz power 
frequency fields have been epidemiologically associated with 
increased risk of cancer. Remarkably, under the conditions of 
our experiments both kinds of fields had similar effects on 
Jurkat cell growth, decreasing the extent of [3H] thymidine 
incorporation into treated cells in 20 of 24 experiments shown 
in Figs. 2 and 3 and Table 1. 
Generally, the physiological effect of exposure to fields was 
delayed with significant effects on DNA synthesis first becom-
ing apparent 24-48 h after exposure to EMFs and increasing 
in magnitude over the next 48 h. Thus, the result of EMF 
exposure during one round of the cell cycle was not apparent 
as an effect on DNA synthesis until the next and succeeding 
rounds of the cell cycle. The fact that [3H] thymidine incor-
poration into DNA continued to be inhibited and that EMF 
effects became more prominent during the remainder of cul-
ture growth strongly indicates that EMFs permanently pre-
vented subpopulations of the cultures from cycling. 
Alternative interpretations of our results include the possi-
bility that EMFs only inhibited the [3H] thymidine uptake 
involved in DNA repair and/or that extracellular [3H] thymi-
dine transport was inhibited [12]. Since the EMF effect was 
not most prominent immediately after EMF exposure, but 
occurred several generations later, we conclude that the 
EMF effect is not due to inhibition of DNA repair or tran-
siently altered [3H] thymidine transport. 
In most of our experiments EMFs decreased DNA synthe-
sis and the magnitude of this effect was only weakly depend-
ent on the physical characteristics of the fields. We were sur-
prised at this outcome since many studies indicate that special 
frequencies, waveforms and intensities (windows) are required 
to generate a specific biological reaction [13,14]. Although all 
the fields were qualitatively similar in their effect on DNA 
synthesis, the 1.8 mT bone healing field generally caused 
more prominent biological effects than the 60 Hz fields. Since 
the 0.1 and 0.4 mT, 60 Hz fields did not show a dose response 
relationship, we conclude that the 60 Hz EMF effect on [3H] 
thymidine uptake of Jurkat cells, is already saturated at 0.1 
mT. Similar results are reported from EMF induced Ca2+ 
oscillations in Jurkat cells [15]. To further support this idea, 
Liburdy and others have shown, in other cell types, that 60 
Hz sinusoidal fields with intensities as low as 1.2 μΤ have 
reproducible biological effects [16,17]. Finally, we calculated 
the electric fields induced in our samples and found that the 
bone healing field had a 90-fold greater field density than the 
0.1 mT 60 Hz field and a corresponding 22.5-fold greater field 
density than the 0.4 mT 60 Hz field. From this perspective the 
bone healing field is again clearly more energetic than the 60 
Hz fields and again the 60 Hz fields appear to be saturated 
with the 0.1 mT magnetic field. 
Our data indicate that the metabolic state and/or culture 
conditions of cells is an important variable in determining the 
outcome of exposure to EMFs. We found that cells taken 
from various stages in the growth curve, reintroduced into 
new culture medium (complete or conditioned), and then ex-
posed to magnetic fields exhibited growth stage dependent 
EMF effects. Early log phase cells (stage 1) displayed only 
small EMF effects, middle log phase cells exhibited larger 
EMF effects, and late log phase cells were relatively insensitive 
to EMFs. Additionally, cells replated in conditioned medium 
generally exhibited reduced growth compared to cells in com-
plete medium and the EMF effect was more prominent under 
these conditions. These results might explain the experimental 
variability of the EMF effects that we observed in our early 
experiments (Fig. 1) and the apparent irreproducibility of 
many EMF studies found in the literature. While rigorous 
control of cell growth greatly improves the reproducibility 
of the EMF effects (see Table 1) there are still some uncon-
trolled conditions left in our experiments as can be seen by the 
variability in the time when the most prominent EMF effects 
are seen. In future experiments we plan to control the cell 
cycle and growth stage to determine if EMF sensitivity is 
also cell cycle dependent and if further gains can be made 
in the robustness of the model. 
While this is the first report of EMF effects on proliferation 
of Jurkat cells, there are comparable studies showing EMF 
dependent changes in cell proliferation of mitogen stimulated 
human peripheral blood lymphocytes (PBLs), although there 
is great variability in the reported effects [18]. For example, in 
these studies EMFs have been shown to increase or inhibit 
[3H] thymidine uptake of PBLs. While these differences are 
generally attributed to the physical properties of the fields 
used in the studies, our results suggest that the metabolic state 
of the cells is at least as important as the characteristics of the 
EMFs used in electromagnetic experiments. 
Consistent with our results Pasquinelli et al., 1993 [19] 
found in two leukemic cell lines that exposure to 2 mT, 75 
Hz lowered the DNA synthesis of cells stimulated with dox-
orubicin, an apoptosis inducing drug. Our results are also in 
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agreement with earlier observations on mitogen activated 
PBLs taken from stressed humans or rats. Fields of 22 mT 
(60 Hz) were shown to increase Ca2+ flux in rats and this 
effect was greater in aged animals [20]. Likewise, age related 
EMF effects were shown on cell proliferation in lymphocytes 
from young and aged humans exposed to 2.5 mT, 50 Hz, 
pulsed EMFs [21]. Moreover, Cadossi et al. showed that 
[3H] thymidine uptake of slowly cycling PBLs obtained from 
diseased donors was more sensitive to power frequency EMFs 
than the rapidly cycling PBLs obtained from healthy donors 
[22]. 
The main objective of this study was to determine if Jurkat 
cells respond to EMFs with biologically significant, long last-
ing, effects. It is known that EMFs induce the appearance of 
CD3 epitopes on Jurkat cells [8,9]. Additionally, activation of 
Jurkat cells with anti-CD3 is known to induce cell cycle arrest 
with inhibition of DNA synthesis [23]. However, it has not 
been reported that EMFs capable of inducing anti-CD3 epit-
opes could also bring about downstream effects on DNA syn-
thesis. This study bridges that gap by demonstrating that 
power frequency EMFs, capable of inducing CD3 epitopes 
on Jurkat cells are also capable of inducing cell cycle arrest 
with attendant inhibition of DNA synthesis. A secondary ob-
jective was to determine if EMFs with widely differing phys-
ical characteristics can have similar biological end points. The 
bone healing field and the power frequency field are markedly 
different but, surprisingly, have qualitatively similar, inhibi-
tory effects on DNA synthesis in Jurkat cells. All the effects 
we observe can be explained by EMF activation of the T-cell 
receptor or by direct interaction with downstream compo-
nents of signal transduction pathways [5-7]. Since many dis-
ease states involve inappropriate regulation of cell growth and 
differentiation it is likely that continuing study of the role of 
EMFs in activation and proliferation of T-lymphocytes will 
account for many of the health related effects of exposure to 
EMFs [l^l·]. 
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